5,5-difluoro-2,7-di(propan-2-yl)-2,7-diazaspiro[3.5]nonane;ethane;3-ethyl-9-methyl-3-azaspiro[5.5]undecane
C30H61F2N3 — CID 177029011
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5,5-difluoro-2,7-di(propan-2-yl)-2,7-diazaspiro[3.5]nonane;ethane;3-ethyl-9-methyl-3-azaspiro[5.5]undecane
5,5-difluoro-2,7-di(propan-2-yl)-2,7-diazaspiro[3.5]nonane;ethane;3-ethyl-9-methyl-3-azaspiro[5.5]undecane (PubChem CID 177029011) has the molecular formula C30H61F2N3 and a molecular weight of 501.84 g/mol. Its IUPAC name is 5,5-difluoro-2,7-di(propan-2-yl)-2,7-diazaspiro[3.5]nonane;ethane;3-ethyl-9-methyl-3-azaspiro[5.5]undecane.
Molecular Properties
| Compound Name | 5,5-difluoro-2,7-di(propan-2-yl)-2,7-diazaspiro[3.5]nonane;ethane;3-ethyl-9-methyl-3-azaspiro[5.5]undecane |
|---|---|
| PubChem CID | 177029011 |
| Molecular Formula | C30H61F2N3 |
| Molecular Weight | 501.84 g/mol |
| Exact Mass | 501.48 |
| IUPAC Name | 5,5-difluoro-2,7-di(propan-2-yl)-2,7-diazaspiro[3.5]nonane;ethane;3-ethyl-9-methyl-3-azaspiro[5.5]undecane |
| SMILES | CC.CC.CC(C)N1CCC2(CN(C(C)C)C2)C(F)(F)C1.CCN1CCC2(CCC(C)CC2)CC1 |
| InChI | InChI=1S/C13H24F2N2.C13H25N.2C2H6/c1-10(2)16-6-5-12(13(14,15)9-16)7-17(8-12)11(3)4;1-3-14-10-8-13(9-11-14)6-4-12(2)5-7-13;2*1-2/h10-11H,5-9H2,1-4H3;12H,3-11H2,1-2H3;2*1-2H3 |
| InChIKey | QCMNIAHRHVYRKS-UHFFFAOYSA-N |
| XLogP | 7.80 |
| TPSA | 9.72 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 501.84 |
| LogP ≤ 5 | 7.80 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177029011 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.